Letter: Multiple Factors Could Affect Blood Pressure in Patients With COVID-19

Abstract

Keywords

hypertension coronavirus COVID-19

Get full access to this article

View all access options for this article.

References

Akpek

. Does COVID-19 cause hypertension? Angiology. Published online December 10, 2021;1-6.

Yang

Zhao

, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020;109(5):531-538.

Williams

Mancia

Spiering

, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021-3024.

McCarthy

Wenceslau

Goulopoulou

Ogbi

Matsumoto

Webb

. Autoimmune therapeutic chloroquine lowers blood pressure and improves endothelial function in spontaneously hypertensive rats. Pharmacol Res. 2016;113(Pt A):384-394.

McCarthy

Wenceslau

Goulopoulou

Baban

Matsumoto

Webb

. Chloroquine suppresses the development of hypertension in spontaneously hypertensive rats. Am J Hypertens. 2017;30(2):173-181.

Zhang

, et al. Pharmacological and cardiovascular perspectives on the treatment of COVID-19 with chloroquine derivatives. Acta Pharmacol Sin. 2020;41(11):1377-1386.

Anigbogu

Adigun

Inyang

Adegunloye

. Chloroquine reduces blood pressure and forearm vascular resistance and increases forearm blood flow in healthy young adults. Clin Physiol. 1993;13(2):209-216.